The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Geroscience for the Next Chapter of Medicine
Abstract
In 1863, Rudolph Virchow published “Cellular Pathology as Based upon Physiological and Pathological Histology,” establishing for the first time that cellular pathology was tightly connected with human pathology (1). Over subsequent years, the intuition of Dr. Virchow became the driver of scientific discovery in medical science, and the understanding of cell physiology and pathology expanded our knowledge of the pathophysiology of acute and chronic diseases. This understanding had fundamental roles in identifying targets for preventing, curing, and modifying human disease. Today, accumulating evidence from the field of geroscience promises to make a similar impact on medicine and public health. Curiosity about the origin of aging is probably as old as the human species. With the rising evidence that the pace of aging is malleable in animal models, research on the biological mechanisms of aging has expanded more than ever before, moving from interesting speculation to a science at the front edge of medicine. As scientists investigated the molecular and cellular mechanisms of aging biology, they discovered that the “mechanisms of aging” are, in fact, failures of homeostatic mechanisms that maintain life with attendant cellular damage and dysfunction driving deficit accumulation that manifests clinically as chronic diseases and decline of physical and cognitive functions (2). More recent discoveries of factors that preserve or restore youthful molecular and cellular processes in animal models have suggested that the pace of aging is malleable, and we can enhance healthy longevity (3). These exciting observations gave birth to the field of geroscience, where expanding the focus of aging research from the mechanisms of aging to the mechanisms of life has tremendous implications. Geroscience encompasses a life course approach because the decline of efficiency of the mechanisms that protect from damage accumulation likely starts early. The balance between damage accumulation and damage avoidance and repair may be tilted by intrinsic and extrinsic stressors or the progressive weakening of resilience strategies. This balance affects health stability before any clinical evidence of diseases emerges. It also connects current and future health to social, economic, psychological, and environmental experiences, breaking the boundaries between medical care and public health (4). Last but not least, “gerotherapeutics” target fundamental resilience strategies to improve health span and prevent or delay the onset of multiple diseases in older age. Many trials of potential therapeutic agents are currently underway. The modern concept of geroscience was developed by Felipe Sierra and Ron Kohanski in collaboration with other scientists when Dr. Sierra was still working at the National Institute on Aging (NIA) (5). NIA is fully committed to advancing progress in this important new branch of science and, in this context, is promoting the fourth Geroscience Summit, which will be held in Bethesda on April 24–26, 2023, at the Natcher Conference Center, and is aimed to review and discuss the state-of-the-art accomplishments in this field (https://www.nia.nih.gov/2023-fourth-geroscience-summit). The aims of the Summit are diverse and highly interconnected. They include: (i) understand how geroscience can become a more inclusive approach to medical care for all people and help address health disparities; (ii) explore mechanisms that, during aging, increase susceptibility to multimorbidity and geriatric syndromes; (iii) discuss conceptual development of “measures” of the pace of aging as well as characteristics and performance of currently available measures; (iv) consider the importance and utility of mathematical modeling and artificial intelligence in geroscience; (v) discuss the new design features that will be required to implement geroscience clinical trials. These topics touch on the most innovative and essential aspects of the geroscience initiative. There is strong evidence that complex biological, environmental, sociocultural, and behavioral factors affect the quality of aging and substantially influence health disparities across individuals and communities. However, key domains of exposures and biological mechanisms that mediate these associations and may be targeted for interventions are ripe for further exploration, especially if considered from a life course perspective. The geroscience hypothesis acknowledges that aging causes global susceptibility to diseases clinically emerging as multimorbidity and frailty. Thus, the study of special populations that experience accelerated trajectories of comorbid diseases or those with exceptional health at older ages (eg, centenarians) provides clues about the mechanisms of such susceptibility or resistance and may inform biological research on health disparities related to aging. The translation of these concepts to prevention and care in older patients will necessarily require the d
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, until it becomes possible to modulate the biological rate of aging43 and fundamentally alter the primary factors that drive human health and longevity44, radical life extension in already long-lived national populations remains implausible in this century.”
From Implausibility of radical life extension in humans in the twenty-first century (2024) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hazzard’s Geriatric Medicine and Gerontology
Dwolatzky, T. (2009) · JAMA · doi:10.1001/jama.2009.1561 · Cited by 521
As Based upon Physiological and Pathological Histology: CELLULAR PATHOLOGY.
VIRCHOW, R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1989.tb02747.x · Cited by 345
Cellular pathology as based upon physiological and pathological histology ...
Virchow, R. (1863) · J.B. Lippincott eBooks · doi:10.5962/bhl.title.32770 · Cited by 217
Sierra, F. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025163 · Cited by 210
Robbins, P. D., & Niedernhofer, L. J. (2017) · Aging Cell · doi:10.1111/acel.12620 · Cited by 12
Geroscience Brings New Focus on the Life-Course Approach to Health in Humans
Ferrucci, L. (2020) · Innovation in Aging · doi:10.1093/geroni/igaa057.2914 · Cited by 4
Self-citation
Research works printed but not linked: 1
- Kuchel, 2017, Aging and homeostatic regulation., 681
Cited by
Implausibility of radical life extension in humans in the twenty-first century
Olshansky, S. J., Willcox, B. J., Demetrius, L., & Beltrán-Sánchez, H. (2024) · Nature Aging · doi:10.1038/s43587-024-00702-3 · Cited by 115
Metadata
- Authors
- Duque, G., Lipsitz, L. A., Ferrucci, L., Addie, S., Carrington-Lawrence, S., & Kohanski, R.
- Affiliations
- Research Institute of the McGill University Health Centre , Montreal, Quebec , Canada
- Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife , Roslindale, Massachusetts , USA
- Longitudinal Studies Section, National Institute on Aging, National Institutes of Health , Baltimore, Maryland , USA
- Division of Aging Biology, National Institute on Aging, National Institutes of Health , Bethesda, Maryland , USA
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-05-01
- Volume
- 78
- Issue
- 5
- Pages
- 791-792
- ISSN
- 1079-5006
- 1758-535X
- Cited by
- 7
- References
- 6
- Language
- en
- Funders
- NIH
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Geroscience for the Next Chapter of Medicine. https://app.cochat.ai/papers/10.1093/gerona/glad083
- The paper
- Duque, G., Lipsitz, L. A., Ferrucci, L., Addie, S., Carrington-Lawrence, S., & Kohanski, R. (2023). Geroscience for the Next Chapter of Medicine. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glad083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.